Authors
Joanna Rhodes, MD, MSCE, is the director of the lymphoma program at the Rutgers Cancer Institute and assistant head of lymphoma at Robert Wood Johnson.
Christopher Shade, PhD, founder and CEO, Quicksilver Scientific.
Advertisement
Advertisement
Trending on AJMC
1
AI Chatbots Score Below 28% on Colorectal Cancer Questions
2
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
3
5 Notable FDA Approvals From the First Half of 2026
4
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
5
